The Impact of Maternal Probiotics on Intestinal Vitamin D Receptor Expression in Early Life
dc.contributor.author | Sharma, Anita | |
dc.contributor.author | Yu, Yueyue | |
dc.contributor.author | Lu, Jing | |
dc.contributor.author | Lu, Lei | |
dc.contributor.author | Zhang, Yong-Guo | |
dc.contributor.author | Xia, Yinglin | |
dc.contributor.author | Sun, Jun | |
dc.contributor.author | Claud, Erika C | |
dc.date.accessioned | 2023-05-20T17:19:20Z | |
dc.date.available | 2023-05-20T17:19:20Z | |
dc.date.issued | 2023-05-16 | |
dc.identifier.issn | 2218-273X | |
dc.identifier.uri | https://hdl.handle.net/2027.42/176376 | |
dc.description.abstract | <jats:p>Vitamin D signaling via the Vitamin D Receptor (VDR) has been shown to protect against intestinal inflammation. Previous studies have also reported the mutual interactions of intestinal VDR and the microbiome, indicating a potential role of probiotics in modulating VDR expression. In preterm infants, although probiotics have been shown to reduce the incidence of necrotizing enterocolitis (NEC), they are not currently recommended by the FDA due to potential risks in this population. No previous studies have delved into the effect of maternally administered probiotics on intestinal VDR expression in early life. Using an infancy mouse model, we found that young mice exposed to maternally administered probiotics (SPF/LB) maintained higher colonic VDR expression than our unexposed mice (SPF) in the face of a systemic inflammatory stimulus. These findings indicate a potential role for microbiome-modulating therapies in preventing diseases such as NEC through the enhancement of VDR signaling.</jats:p> | |
dc.language | en | |
dc.publisher | MDPI AG | |
dc.title | The Impact of Maternal Probiotics on Intestinal Vitamin D Receptor Expression in Early Life | |
dc.type | Article | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176376/2/biomolecules-13-00847.pdf | |
dc.identifier.doi | 10.3390/biom13050847 | |
dc.identifier.doi | https://dx.doi.org/10.7302/7225 | |
dc.identifier.source | Biomolecules | |
dc.description.version | Published online | |
dc.date.updated | 2023-05-20T17:19:17Z | |
dc.identifier.orcid | 0000-0002-0153-9361 | |
dc.identifier.orcid | 0000-0001-6857-7437 | |
dc.identifier.orcid | 0000-0001-7465-3133 | |
dc.description.filedescription | Description of biomolecules-13-00847.pdf : Published version | |
dc.identifier.volume | 13 | |
dc.identifier.issue | 5 | |
dc.identifier.startpage | 847 | |
dc.identifier.endpage | 847 | |
dc.identifier.name-orcid | Sharma, Anita | |
dc.identifier.name-orcid | Yu, Yueyue | |
dc.identifier.name-orcid | Lu, Jing; 0000-0002-0153-9361 | |
dc.identifier.name-orcid | Lu, Lei | |
dc.identifier.name-orcid | Zhang, Yong-Guo | |
dc.identifier.name-orcid | Xia, Yinglin; 0000-0001-6857-7437 | |
dc.identifier.name-orcid | Sun, Jun; 0000-0001-7465-3133 | |
dc.identifier.name-orcid | Claud, Erika C | |
dc.working.doi | 10.7302/7225 | en |
dc.owningcollname | Pediatrics and Communicable Diseases, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.